Nanobody-drug conjugates

Nanobodies are well-known in therapeutic medicine and structural biology. We are current collaborating with a Biotech company to derive new nanobodies for GPCR-related diseases. Future work will involve conjugation of specific warheads to nanobodies.

Scholarly Lite is a free theme, contributed to the Drupal Community by More than Themes.